Instil Bio, Inc. (TIL) Stock Analysis

Company Overview

Instil Bio, Inc. (TIL) carries a market capitalisation of $51.41M. The company sits in the Healthcare sector, in the Biotechnology industry. The company reports 17 employees.

TIL last closed at $7.58 on September 4, 2026. That is −$0.08 (−1.04%) against the previous close. Over the past 52 weeks the price has ranged from $5.67 to $30.50. The latest close sits 33.69% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $71.37M. Profit margin runs at 0%. Earnings per share on a trailing basis come to −4.4.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The trailing one-year price return is −75.00%. Across 5 years the annualized return works out at −55.40%. Beta against the wider market is reported at 1.92. Daily returns over the trailing 5 years annualize to a volatility of 106.8%.

Growth & Income

The record shows no dividend for TIL.

Across the complete calendar years on file, 2024 returned +150.52% and 2022 returned −96.32%. Of the 4 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −31.09% year to date.